Histoplasma capsulatum cell wall β-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: Correlation with leukotriene B 4 generation and role in HIV-1 infection

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4025-4035

  Sorgi, Carlos Artério ^a   Secatto, Adriana ^a   Fontanari, Caroline ^a   Turato, Walter Miguel ^a   Belangér, Caroline ^b   De Medeiros, Alexandra Ivo ^a   Kashima, Simone ^a   Marleau, Sylvie ^b   Covas, Dimas Tadeu ^a   Bozza, Patrícia Torres ^c   Faccioli, Lúcia Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CD18 ANTIGEN; DECTIN 1; DECTIN 1 RECEPTOR; ICOSANOID; LECTIN RECEPTOR; LEUKOTRIENE B4; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; LIPID; MEMBRANE PROTEIN; NERVE PROTEIN;

ADULT; ARTICLE; CELL ORGANELLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICOSANOID METABOLISM; INNATE IMMUNITY; MALE; MONOCYTE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL WALL; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPLASMA; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; MOUSE; MOUSE MUTANT;

ADULT; ANIMALS; ANTIGENS, CD18; BETA-GLUCANS; CELL WALL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE B4; LIPIDS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NERVE TISSUE PROTEINS; ORGANELLES; TOLL-LIKE RECEPTOR 2;

EID: 64249111147     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801795     Document Type: Article

References (52)

1. Cano, M. V., and R. A. Hajjeh. 2001. The epidemiology of histoplasmosis: a review. Semin. Respir. Infect. 16: 109-118.
2. Wheat, L. J., P. A. Connolly-Stringfield, R. L. Baker, M. F. Curfman, M. E. Eads, K. S. Israel, S. A. Norris, D. H. Webb, and M. L. Zeckel. 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 69: 361-374.
3. Wheat, J. 1996. Histoplasmosis in the acquired immunodeficiency syndrome. Curr. Top. Med. Mycol. 7: 7-18.
4. Coffey, M. J., S. M. Phare, P. H. Kazanjian, and M. Peters-Golden. 1996. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J. Immunol. 157: 393-399.
5. Coffey, M. J., S. M. Phare, S. Cinti, M. Peters-Golden, and P. H. Kazanjian. 1999. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocytes and neutrophils in acquired immunodeficiency syndrome. Blood 94: 3897-3905.
6. Coffey, M. J., S. M. Phare, S. George, M. Peters-Golden, and P. H. Kazanjian. 1998. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J. Clin. Invest. 102: 663-670.
7. Newman, S. L. 1999. Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol. 7: 67-71. (Pubitemid 29273937)
8. Allendoerfer, R., and G. S. Deepe, Jr. 1998. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160: 6072-6082.
9. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155: 785-795.
10. Deepe, G. S., Jr., R. Gibbons, and E. Woodward. 1999. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J. Immunol. 163: 4985-4993.
11. Smith, J. G., D. M. Magee, D. M. Williams, and J. R. Graybill. 1990. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 162: 1349-1353.
12. Medeiros, A. I., C. L. Silva, A. Malheiro, C. M. Maffei, and L. H. Faccioli. 1999. Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the β-glucan present in their cell wall. Br. J. Pharmacol. 128: 1529-1537.
13. Medeiros, A. I., A. Sa-Nunes, E. G. Soares, C. M. Peres, C. L. Silva, and L. H. Faccioli. 2004. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immun. 72: 1637-1644.
14. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
15. Woods, J. W., M. J. Coffey, T. G. Brock, I. I. Singer, and M. Peters-Golden. 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95: 2035-2046.
16. Weller, P. F., P. T. Bozza, W. Yu, and A. M. Dvorak. 1999. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 118: 450-452.
17. Murphy, D. J. 2001. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 40: 325-438.
18. D'Avila, H., R. C. Melo, G. G. Parreira, E. Werneck-Barroso, H. C. Castro-Faria-Neto, and P. T. Bozza. 2006. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 176: 3087-3097. (Pubitemid 43306971)
19. Melo, R. C., H. D'Avila, D. L. Fabrino, P. E. Almeida, and P. T. Bozza. 2003. Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell 35: 59-67.
20. Pacheco, P., F. A. Bozza, R. N. Gomes, M. Bozza, P. F. Weller, H. C. Castro-Faria-Neto, and P. T. Bozza. 2002. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular loci involved in eicosanoid metabolism. J. Immunol. 169: 6498-6506. (Pubitemid 36903501)
21. Bozza, P. T., R. C. Melo, and C. Bandeira-Melo. 2007. Leukocyte lipid bodies regulation and function: contribution to allergy and host defense. Pharmacol Ther. 113: 30-49.
22. Bozza, P. T., W. Yu, J. F. Penrose, E. S. Morgan, A. M. Dvorak, and P. F. Weller. 1997. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J. Exp. Med. 186: 909-920.
23. Bozza, P. T., J. L. Payne, J. L. Goulet, and P. F. Weller. 1996. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 183: 1515-1525.
24. 4 production in eosinophils and basophils. J. Biol. Chem. 276: 22779-22787.
25. 4 synthesis within eosinophils. Am. J. Respir. Cell Mol. Biol. 33: 254-261.
26. 4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 179: 8500-8508.
27. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196: 407-412.
28. Maya-Monteiro, C. M., P. E. Almeida, H. D'Avila, A. S. Martins, A. P. Rezende, H. Castro-Faria-Neto, and P. T. Bozza. 2008. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 283: 2203-2210.
29. Mancuso, P., T. J. Standiford, T. Marshall, and M. Peters-Golden. 1998. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect. Immun. 66: 5140-5146. (Pubitemid 29044602)
30. Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17: 593-623.
31. Brown, G. D., and S. Gordon. 2001. Immune recognition. A new receptor for β-glucans. Nature 413: 36-37.
32. Hahn, P. Y., S. E. Evans, T. J. Kottom, J. E. Standing, R. E. Pagano, and A. H. Limper. 2003. Pneumocystis carinii cell wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J. Biol. Chem. 278: 2043-2050.
33. Lebron, F., R. Vassallo, V. Puri, and A. H. Limper. 2003. Pneumocystis carinii cell wall β-glucans initiate macrophage inflammatory responses through NF-κB activation. J. Biol. Chem. 278: 25001-25008. (Pubitemid 37548662)
34. McCann, F., E. Carmona, V. Puri, R. E. Pagano, and A. H. Limper. 2005. Macrophage internalization of fungal β-glucans is not necessary for initiation of related inflammatory responses. Infect. Immun. 73: 6340-6349. (Pubitemid 41368795)
35. 2 integrin, CD11b. J. Immunol. 181: 2907-2915.
36. Kimberg, M., and G. D. Brown. 2008. Dectin-1 and its role in antifungal immunity. Med. Mycol. 46: 631-636.
37. Bittencourt, V. C., R. T. Figueiredo, R. B. da Silva, D. S. Mourao-Sa, P. L. Fernandez, G. L. Sassaki, B. Mulloy, M. T. Bozza, and E. Barreto-Bergter. 2006. An α-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation. J. Biol. Chem. 281: 22614-22623. (Pubitemid 44242290)
38. Bartemes, K. R., S. McKinney, G. J. Gleich, and H. Kita. 1999. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J. Immunol. 162: 2982-2989.
39. Silva, A. R., E. F. de Assis, L. F. Caiado, G. K. Marathe, M. T. Bozza, T. M. McIntyre, G. A. Zimmerman, S. M. Prescott, P. T. Bozza, and H. C. Castro-Faria-Neto. 2002. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J. Immunol. 168: 4112-4120.
40. Horie, S., and H. Kita. 1994. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J. Immunol. 152: 5457-5467. (Pubitemid 24152995)
41. Medeiros, A. I., V. L. Bonato, A. Malheiro, A. R. Dias, C. L. Silva, and L. H. Faccioli. 2002. Histoplasma capsulatum inhibits apoptosis and Mac-1 expression in leucocytes. Scand. J. Immunol. 56: 392-398.
42. Soberman, R. J., and P. Christmas. 2003. The organization and consequences of eicosanoid signaling. J. Clin. Invest. 111: 1107-1113.
43. Peters-Golden, M., and T. G. Brock. 2000. Intracellular compartmentalization of leukotriene biosynthesis. Am. J. Respir. Crit. Care Med. 161: S36-S40.
44. Bozza, P. T., and C. Bandeira-Melo. 2005. Mechanisms of leukocyte lipid body formation and function in inflammation. Mem. Inst. Oswaldo Cruz 100(Suppl. 1): 113-120.
45. Centers for Disease Control, U.S. Department of Health and Human Services. 1986. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann. Intern. Med. 105: 234-237.
46. Hober, D., F. Ajana, M. C. Petit, C. Sartiaux, M. Boniface, M. Caillaux, Y. Mouton, P. Wattre, and M. Maniez-Montreuil. 1993. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792. (Pubitemid 23356116)
47. Pitrak, D. L., P. M. Bak, P. DeMarais, R. M. Novak, and B. R. Andersen. 1993. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J. Infect. Dis. 167: 1406-1410. (Pubitemid 23146192)
48. Casotti, J. A., T. Q. Motta, C. U. Ferreira Junior, and C. Cerutti, Jr. 2006. Disseminated histoplasmosis in HIV positive patients in Espirito Santo state, Brazil: a clinical-laboratory study of 12 cases (1999 -2001). Braz J. Infect. Dis. 10: 327-330.
49. 2, PAF, and vitronectin receptor. AIDS Res. Hum. Retroviruses 22: 763-769.
50. 2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J. Immunol. 173: 559-565.
51. 2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37: 562-570.
52. Demitsu, T., H. Katayama, T. Saito-Taki, H. Yaoita, and M. Nakano. 1989. Phagocytosis and bactericidal action of mouse peritoneal macrophages treated with leukotriene B4. Int. J. Immunopharmacol. 11: 801-808. (Pubitemid 19252367)